Open access · US-GOV
via ClinicalTrials.gov Clinical trial
ZEBinix Retention Rate in Epilepsy in Elderly Patients
Authors not listed
Centre Hospitalier Saint Joseph Saint Luc de Lyon · 2019
Abstract
The incidence of provoked and unprovoked seizures is known to increase with advancing age. Eslicarbazepine acetate (ESL) is one of the third generation of antiepileptic drugs (AEDs) that have been developed in the last ten years with a favorable safety profile. ESL is approved in Europe and the USA as adjunctive or monotherapy in adults with partial-onset seizures. Nevertheless, retrospective data in monotherapy condition in the elderly epileptic population are sparse. The aim of the ZEBRE study is to evaluate the efficacy and the safety of ESL in elderly epileptic patients (\> 65 years). The completion of this study will provide crucial information on the most appropriate ESL treatment for elderly patients suffering from partial seizures.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Anonymous. (2019). ZEBinix Retention Rate in Epilepsy in Elderly Patients. <em>Centre Hospitalier Saint Joseph Saint Luc de Lyon</em>. https://clinicaltrials.gov/study/NCT04221282
Vancouver
Anonymous. ZEBinix Retention Rate in Epilepsy in Elderly Patients. Centre Hospitalier Saint Joseph Saint Luc de Lyon. 2019.
BibTeX
@misc{anon2019ZEBini,
title = {ZEBinix Retention Rate in Epilepsy in Elderly Patients},
author = {Anonymous},
journal = {Centre Hospitalier Saint Joseph Saint Luc de Lyon},
year = {2019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Galaxia Empírica 2023
Open access · US-GOV
Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria
The First Affiliated Hospital with Nanjing Medical University 2012
Open access · US-GOV
A Prospective, Single-arm, Open-label, Phase 2 Study to Evaluate Efficacy and Safety of R-GemOx Regimen as First-line Treatment in Elderly Patients With Diffuse Large B-cell Lymphoma (DLBCL).
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 2025
Open access · US-GOV
A Phase III, Randomized, Double-blinded Study of the Efficacy and Safety of LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome (the LESS-AD Trial).
ENCell 2027
Open access · US-GOV
A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial to Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia
Astellas Institute for Regenerative Medicine 2013
Open access · US-GOV
Follow-up to 5 Years of a Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Buck Institute for Research on Aging 2022
Open access · US-GOV